Potential Abuses Within U.S. Pharmaceutical Patent Regulation
By Tony Pistilli · Society of Actuaries · 2021
Study guide: Exam GH-201U
An article in The Actuary, February 2021, on how some pharmaceutical manufacturers have used patent laws to gain extended patent lifespans and deter legal challenges, which consumer advocates note increases costs to consumers by delaying generic entrants. It covers potential abuses of patents as well as proposed reforms to patent laws to address them.
On the syllabus
- Exam GH-201U — Outcomes 3b; the whole article.
Description of Potential Patent Abuses
Recent Legislative Proposals
Conclusion
Sources
- Potential Abuses Within U.S. Pharmaceutical Patent Regulation (Tony Pistilli, The Actuary, February 2021) — the document: title, author, date, opening paragraphs and section headings
- SOA GH 201U syllabus, Nov 2026/Mar 2027/Jul 2027 — the citation and the assigned scope